ARVINAS, INC. Restructuring Reserve
ARVINAS, INC. (ARVN) had Restructuring Reserve of $0 as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2026-08-04
- 2026-06-30: Restructuring Reserve $0.00.
- 2026-03-31: Restructuring Reserve $1.60M.
- 2025-12-31: Restructuring Reserve $4.40M.
- 2025-09-30: Restructuring Reserve $4.10M.
| Period end | Restructuring Reserve |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-04 |
| 2026-03-31 | $1.60M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $4.40M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $4.10M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $2.20M 10-Q · filed 2025-08-06 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |